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Oral administration of the Salmonella Typhimurium vaccine strain Nal2/Rif9/Rtt to 
chicks at day of hatch reduces shedding and caecal colonization after challenge with a 
monophasic variant of Salmonella Typhimurium. 
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A monophasic variant of Salmonella Typhimurium, Salmonella enterica serotype 
1,4,[5],12:i:– is rapidly emerging worldwide. This serotype is now considered to be among 
the ten most common serovars isolated from humans in many countries. The public health risk 
posed by these emerging monophasic Salmonella Typhimurium strains is considered 
comparable to that of classical Salmonella Typhimurium strains. The serotype 1,4,[5],12:i:– is 
frequently isolated from pigs but also poultry is carrying strains from this serotype. In the 
current study, we evaluated the efficacy of the Salmonella Typhimurium strain Nal2/Rif9/Rtt 
strain (contained in the commercially available live vaccines AviPro® Salmonella Duo and 
AviPro® Salmonella VacT), to protect against infection with the emerging monophasic 
variant in poultry. Three independent trials were conducted. In all trials, laying type chicks 
were orally vaccinated with the Salmonella Typhimurium strain Nal2/Rif9/Rtt at day of hatch, 
while the birds were challenged the next day with a different infection dose in each trial (low, 
high and intermediate). For the intermediate dose study, a seeder bird model was used in 
which 1 out of 3 animals were challenge infected. All individual birds were infected in the 
other trials. Data obtained from each independent trial show that oral administration of the 
Salmonella Typhimurium strain Nal2/Rif9/Rtt at day of hatch reduced shedding, caecal and 
internal organ colonization of Salmonella Typhimurium 1,4,[5],12:i:–, administered at day 2 
of life, suggesting protection through a colonization-inhibition phenomenon. This indicates 
that Salmonella Typhimurium strain Nal2/Rif9/Rtt can help to control Salmonella 
1,4,[5],12:i:– infections in poultry.  
 
